Table 2.
Control | Alzheimer’s disease | |||
---|---|---|---|---|
ApoE 3/3 | ApoE 3/4 | ApoE 4/4 | ||
Basal nucleus of Meynert | ||||
Dendritic length (mm) | 2.612 ± 0.049 | 3.600 ± 0.0472-165 | 3.353 ± 0.0452-165## | 3.275 ± 0.0362-165### |
Neuronal density (%) | 100 | 36.3 ± 3.82-165 | 26.6 ± 3.92-165 | 13.4 ± 2.92-165## |
Locus coeruleus | ||||
Dendritic length (mm) | 2.230 ± 0.041 | 3.021 ± 0.0312-165 | 2.838 ± 0.0272-165### | 2.732 ± 0.0192-165### |
Neuronal density (%) | 100 | 49.9 ± 3.52-165 | 33.1 ± 5.32-165## | 14.2 ± 5.02-165### |
Raphe magnus nucleus | ||||
Dendritic length (mm) | 2.520 ± 0.026 | 2.982 ± 0.0212-165 | 2.922 ± 0.0272-165 | 2.855 ± 0.0292-165### |
Neuronal density (%) | 100 | 70.3 ± 2.22-165 | 62.5 ± 8.52-165 | 49.1 ± 3.72-165### |
Medial amygdaloid nucleus | ||||
Dendritic length (mm) | 2.342 ± 0.026 | 2.776 ± 0.0222-165 | 2.730 ± 0.0282-165 | 2.654 ± 0.0302-165## |
Neuronal density (%) | 100 | 75.1 ± 2.12-165 | 66.3 ± 2.82-165# | 44.1 ± 3.72-165### |
Pedunculopontine tegmental nucleus | ||||
Dendritic length (mm) | 2.410 ± 0.024 | 2.867 ± 0.0202-165 | 2.805 ± 0.0322-165 | 2.733 ± 0.0252-165## |
Neuronal density (%) | 100 | 77.7 ± 3.82-165 | 58.8 ± 3.42-165## | 35.4 ± 5.12-165### |
Substantia nigra | ||||
Dendritic length (mm) | 2.155 ± 0.037 | 2.389 ± 0.0302-165 | 2.299 ± 0.0272-160 | 2.256 ± 0.008# |
Neuronal density (%) | 100 | 87.8 ± 1.32-165 | 77.3 ± 2.72-165### | 62.6 ± 4.82-165### |
Data are mean ± SEM. Significantly different from control:
F2-165: p < 0.001;
F2-160: p < 0.01 (Student’st test). Significantly different from AD subgroup ApoE 3/3: ###p < 0.001; ##p < 0.01; #p < 0.05 (Student’s t test). For group size, see Table 1.